# Intraoperative Fascial Traction - From Concept to Comprehensive Application

**Authors:** H. Niebuhr, G. Woeste, C. Winkler, S. Behle, W. Reinpold, H. Dag, F. Köckerling

PMC · DOI: 10.3389/jaws.2026.16018 · Journal of Abdominal Wall Surgery · 2026-02-06

## TL;DR

Intraoperative Fascial Traction is a new surgical technique for abdominal wall reconstruction that can reduce the need for muscle separation and improve outcomes for certain hernia sizes.

## Contribution

The paper introduces a structured treatment algorithm for IFT based on hernia size, enhancing its clinical application and effectiveness.

## Key findings

- IFT achieves fascial closure rates of 79%–96% for hernias below 19 cm.
- The Hamburg algorithm 2.0 recommends IFT as first-line treatment for defects up to 15 cm.
- Combining IFT with BTA and TAR can improve outcomes for larger hernias.

## Abstract

Intraoperative Fascial Traction (IFT) represents a promising alternative technique for complex abdominal wall reconstruction in large ventral hernias, particularly those exceeding 10 cm in width. Developed by Swiss and German surgeons and introduced clinically in 2021, IFT achieves fascial closure without extensive muscle component separation. Multiple studies demonstrate closure rates of 79%–96% for defects below 19 cm, though rates decline significantly for larger defects. Preoperative botulinum toxin A (BTA) administration and transversus abdominis muscle release (TAR) are often combined with IFT. The paper discusses the Hamburg algorithm 2.0 as it provides a structured treatment approach based on defect width, recommending IFT as a first-line intervention for defects up to 15 cm and incorporating additional component separation for larger hernias. Controlled fascial traction allows standardised treatment and can lead to higher fascial closure and lower recurrence rates.

## Full-text entities

- **Diseases:** visceroabdominal disproportion (MESH:D020914), ACS (MESH:C566443), ARS (MESH:D020434), incisional hernia (MESH:D000069290), TAR (MESH:D019042), seroma (MESH:D049291), abdominal compartment syndrome (MESH:D059325), ventral hernia (MESH:D006555), lung disease (MESH:D008171), muscle weakness (MESH:D018908), diabetes (MESH:D003920), SSO (MESH:D013530), botulism (MESH:D001906), aspiration (MESH:D011015), hernia sac (MESH:D000082122), CAWR (MESH:D046449), PRS (MESH:C535274), dysphagia (MESH:D003680), weight loss (MESH:D015431), wound infections (MESH:D014946), Hernia (MESH:D006547), infection (MESH:D007239)
- **Chemicals:** CS (MESH:D002586), Fasciotens (-), nicotine (MESH:D009538)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920249/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12920249/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920249/full.md

---
Source: https://tomesphere.com/paper/PMC12920249